|
|
||||||||
Departments of Medicine (Cardiology), Radiology (Nuclear Medicine)and Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin; Department of Radiology, Duke University, Durham, North Carolina
Correspondence: For correspondence or reprints contact: Charles K Stone, MD, Cardiology Section, H6/317 Clinical Sciences Center, 600 Highland Avenue, University of Wisconsin Madison, Madison, WI 53792-3248.
ABSTRACT
The objectives of this study were to determine the relationship of FTHA uptake to changes in perfusion and fatty acid oxidation and to conlirm the retention of FTHA in the mammalian heart. Methods: Six pigs with extracorporeal perfusion of the left anterior descending artery (LAD) and cannulation of the LAD vein were studied. The extraction fraction (EF) of FTHA measured from LAD arterial and venous blood samples, was compared to beta-oxidation rates, determined by water production from tritiated palmitate. After a baseline period,changes in FTHA EF were measured in 15-min periods of hyperemia, control (baseline flow rate) and lactate infusion. After the lactate infusion, FTHA infusion was terminated, and a 15-min washout period was observed. Results: Beta-oxidation rate was unchanged from the baseline period during the hyperemic and control periods. With lactate infusion, the expected myocardial preference for lactate was noted, with a decline in exogenous fatty acid oxidation. Fluorine-18-FTHA EF paralleled the changes in beta-oxidation, with a decrease in EF during lactate infusion. Increase in perfusion was associated with a decrease in FTHA EF, compared to control, such that the product of flow and extractionn was maintained. A linear relationship of FTHA EF to fractional tritiated water production was found. Washout analysis confirmed minimal washout of tracer at 15 min after termination of infusion. Organic solvent extraction of tissue samples suggested that the majority of tissue radioactivity was protein-bound. Conclusion: In the extracorporeally perfused mammalian heart, FTHA EF declined during suppression of beta-oxidation with lactate infusion and alteration in perfusion without change in fatty acid oxidation rate. The linear relationship of FTHA EF with fractional water production from tritiated palmitate further confirms a correlation of the uptake of FTHA with fatty acid beta-oxidation rate and supports the utility of FTHA in the non invasive determination of fatty acid oxidation rate. Furthermore, the trapped nature of the tracer may allow the use of graphical analysis for the quantification of beta-oxidation rates.
Key Words: fatty acid tracer 14-fluorine-18-fluoro-6-thia-heptade-canoic acid myocardial metabolism fatty acid metabolism fatty acids
This article has been cited by other articles:
![]() |
L. Guiducci, T. Gronroos, M. J. Jarvisalo, J. Kiss, A. Viljanen, A. G. Naum, T. Viljanen, T. Savunen, J. Knuuti, E. Ferrannini, et al. Biodistribution of the Fatty Acid Analogue 18F-FTHA: Plasma and Tissue Partitioning Between Lipid Pools During Fasting and Hyperinsulinemia J. Nucl. Med., March 1, 2007; 48(3): 455 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. DeGrado, M. T. Kitapci, S. Wang, J. Ying, and G. D. Lopaschuk Validation of 18F-Fluoro-4-Thia-Palmitate as a PET Probe for Myocardial Fatty Acid Oxidation: Effects of Hypoxia and Composition of Exogenous Fatty Acids J. Nucl. Med., January 1, 2006; 47(1): 173 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Taylor, T. R. Wallhaus, T. R. DeGrado, D. C. Russell, P. Stanko, R. J. Nickles, and C. K. Stone An Evaluation of Myocardial Fatty Acid and Glucose Uptake Using PET with [18F]Fluoro-6-Thia-Heptadecanoic Acid and [18F]FDG in Patients with Congestive Heart Failure J. Nucl. Med., January 1, 2001; 42(1): 55 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. O. Takala, P. Nuutila, C. Katoh, M. Luotolahti, J. Bergman, M. Maki, V. Oikonen, U. Ruotsalainen, T. Gronroos, M. Haaparanta, et al. Myocardial blood flow, oxygen consumption, and fatty acid uptake in endurance athletes during insulin stimulation Am J Physiol Endocrinol Metab, October 1, 1999; 277(4): E585 - E590. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |